Holistic care in inflammatory bowel disease: is it in REACH?

• by Hyder Said, Calum D Moulton, Ailsa Hart, Laurie Keefer

• January 27, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

Genes Predict Bowel Disease Severity

Large study suggests genetic risk scores could help doctors identify patients who need closer monitoring and earlier treatment

• March 12, 2026

• 2 min

Understanding the Barriers to Care for Individuals Receiving In-Patient Polysomnography: A Retrospective Cohort Study

• by James R. Vallerand, Phuong Uyen Nguyen, Adam G. D’Souza, Sachin R. Pendharkar, Tetyana Kendzerska, Marcus Povitz

• April 30, 2026